Cargando…
Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis
BACKGROUND: Dyslipidemia is a common disorder in systemic lupus erythematosus (SLE) patients. It is still inconclusive whether antimalarial drugs could affect the serum lipids in SLE patients, therefore we conducted a systematic review and meta-analysis of available data to address this issue. METHO...
Autores principales: | Tao, Chen-Yang, Shang, Jin, Chen, Tao, Yu, Dahai, Jiang, Yu-Min, Liu, Dong, Cheng, Gen-Yang, Xiao, Jing, Zhao, Zhan-Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456110/ https://www.ncbi.nlm.nih.gov/pubmed/30946340 http://dx.doi.org/10.1097/MD.0000000000015030 |
Ejemplares similares
-
Lupus Erythematosus Panniculitis in Pregnancy and Antimalarials
por: Srivastava, Ankita
Publicado: (2016) -
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010) -
Malignancy in Systemic Lupus Erythematosus (SLE) Patients
por: Cader, Rizna Abdul, et al.
Publicado: (2018) -
Liver involvement in juvenile systemic lupus erythematosus (SLE)
por: Mariniello, Generosa, et al.
Publicado: (2011) -
Pauci-immune Glomerulonephritis in Systemic Lupus Erythematosus (SLE)
por: Liebowitz, Jason, et al.
Publicado: (2018)